JP2019509281A5 - - Google Patents

Download PDF

Info

Publication number
JP2019509281A5
JP2019509281A5 JP2018545179A JP2018545179A JP2019509281A5 JP 2019509281 A5 JP2019509281 A5 JP 2019509281A5 JP 2018545179 A JP2018545179 A JP 2018545179A JP 2018545179 A JP2018545179 A JP 2018545179A JP 2019509281 A5 JP2019509281 A5 JP 2019509281A5
Authority
JP
Japan
Prior art keywords
composition
terbinafine
derivative
salt
range
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018545179A
Other languages
English (en)
Japanese (ja)
Other versions
JP7796465B2 (ja
JP2019509281A (ja
Filing date
Publication date
Priority claimed from GBGB1605127.8A external-priority patent/GB201605127D0/en
Application filed filed Critical
Publication of JP2019509281A publication Critical patent/JP2019509281A/ja
Publication of JP2019509281A5 publication Critical patent/JP2019509281A5/ja
Priority to JP2023148797A priority Critical patent/JP2023182607A/ja
Application granted granted Critical
Publication of JP7796465B2 publication Critical patent/JP7796465B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018545179A 2016-03-25 2017-03-24 組成物および治療方法 Active JP7796465B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023148797A JP2023182607A (ja) 2016-03-25 2023-09-13 組成物および治療方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1605127.8 2016-03-25
GBGB1605127.8A GB201605127D0 (en) 2016-03-25 2016-03-25 Composition and methods of treatment
PCT/GB2017/050852 WO2017163091A1 (en) 2016-03-25 2017-03-24 Composition and methods of treatment

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023148797A Division JP2023182607A (ja) 2016-03-25 2023-09-13 組成物および治療方法

Publications (3)

Publication Number Publication Date
JP2019509281A JP2019509281A (ja) 2019-04-04
JP2019509281A5 true JP2019509281A5 (enExample) 2020-04-16
JP7796465B2 JP7796465B2 (ja) 2026-01-09

Family

ID=56027421

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018545179A Active JP7796465B2 (ja) 2016-03-25 2017-03-24 組成物および治療方法
JP2023148797A Pending JP2023182607A (ja) 2016-03-25 2023-09-13 組成物および治療方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023148797A Pending JP2023182607A (ja) 2016-03-25 2023-09-13 組成物および治療方法

Country Status (6)

Country Link
US (1) US12678414B2 (enExample)
EP (1) EP3432867A1 (enExample)
JP (2) JP7796465B2 (enExample)
CN (2) CN109562077A (enExample)
GB (1) GB201605127D0 (enExample)
WO (1) WO2017163091A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201710491D0 (en) * 2017-06-30 2017-08-16 Blueberry Therapeutics Ltd Composition and methods of treatment
US12576049B1 (en) 2019-10-08 2026-03-17 Hallux Inc. Onychomycosis treatment methods
JP2022552252A (ja) 2019-10-08 2022-12-15 ハルクス，インコーポレイテッド 爪真菌症治療用組成物及び方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU223343B1 (hu) 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
US20030147925A1 (en) * 1998-09-11 2003-08-07 Samuel P. Sawan Topical dermal antimicrobial compositions, methods for generating same, and monitoring methods utilizing same
US20020009491A1 (en) 2000-02-14 2002-01-24 Rothbard Jonathan B. Compositions and methods for enhancing drug delivery across biological membranes and tissues
US9149440B2 (en) * 2003-09-02 2015-10-06 University Of South Florida Nanoparticles for drug-delivery
CA2565556A1 (en) * 2004-05-03 2005-12-08 Neosil, Inc. Polycationic antimicrobial therapeutic
WO2007012114A1 (en) 2005-07-25 2007-02-01 Nanotechnology Victoria Pty Ltd Microarray device
US20070249546A1 (en) 2006-04-22 2007-10-25 Sawaya Assad S Ophthalmic and related aqueous solutions containing antifungal agents, uses therefor and methods for preparing them
WO2010011354A2 (en) 2008-07-25 2010-01-28 Innovation Biomedical Devices, Inc. Enchanced trans-keratin drug delivery
AU2010336441B2 (en) 2009-12-23 2015-02-05 Nuvo Research Inc. Highly permeating terbinafine formulation for treating onychomycosis
WO2012092527A1 (en) * 2010-12-29 2012-07-05 Strategic Science & Technologies, Llc Delivery of treatments transdermally for fungal infections and other indications
GB201117538D0 (en) 2011-10-11 2011-11-23 Royal Veterinary College The Methods
EP2664327A1 (en) * 2012-05-14 2013-11-20 Almirall S.A. Topical pharmaceutical compositions comprising terbinafide and urea
US8697753B1 (en) * 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
GB201317005D0 (en) 2013-09-25 2013-11-06 Blueberry Therapeutics Ltd Composition and methods of treatment
GB201511799D0 (en) 2015-07-06 2015-08-19 Blueberry Therapeutics Ltd Composition and methods of treatment

Similar Documents

Publication Publication Date Title
CN105796424B (zh) 一种祛痘组合物及其在化妆品中的应用
JP2016536271A5 (enExample)
CN106456476B (zh) 用于增强碱性有益剂的局部施用的组合物及方法
HRP20191304T1 (hr) Antigljivični pripravak i postupci liječenja
CN105848640A (zh) 包含聚己内酯聚合物的局部用凝胶组合物以及用于增强有益剂的局部施用的方法
CN106075120B (zh) 一种湿疹乳膏剂
JP2012505171A5 (enExample)
BRPI1009190B1 (pt) Solar filter composition
JP2015535214A5 (enExample)
JP2020525428A5 (enExample)
JP5179879B2 (ja) 組成物
CN1262922A (zh) 含至少一种氨基甲酸炔酯和多元醇的化妆或皮肤用组合物
JP2020525460A5 (enExample)
HRP20211009T1 (hr) Topikalna formulacija
CN104434740A (zh) 一种中药祛痘凝胶剂及其制备方法
CN103520072A (zh) 一种含黄腐酸的祛痘面膜及其制备方法
JP2011520773A (ja) 爪の外観の改善
CN103442681B (zh) 一种含有吡啶酮盐和尿囊素的头发去屑组合物
JP6951592B2 (ja) 皮膚感染の予防または治療用組成物
JP2016074737A5 (enExample)
CN105561381B (zh) 一种海洋生物纳米抗菌凝胶液态创可贴的制备方法
CN103877117A (zh) 一种丁酸氢化可的松氧化锌药物组合物
CN112006925A (zh) 一种纳米银抑菌材料及其制备方法和应用
CN108635323B (zh) 一种抗氧化组合物及其在化妆水中的应用
CN107126391A (zh) 一种抗炎修复组合物及其应用